Skip to Main Content

Author Details

Lenore Pereira
University of California san francisco
1976
118
55
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35891239Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas.Vaccines (Basel)2022
31250000Zika Virus Nonstructural Protein 1 Disrupts Glycosaminoglycans and Causes Permeability in Developing Human Placentas.J Infect Dis2020
31065796Survey of cellular immune responses to human cytomegalovirus infection in the microenvironment of the uterine-placental interface.Med Microbiol Immunol2019
31569508Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas.Vaccines (Basel)2019
29106643Zika Virus Replicates in Proliferating Cells in Explants From First-Trimester Human Placentas, Potential Sites for Dissemination of Infection.J Infect Dis2018
30048217Congenital Viral Infection: Traversing the Uterine-Placental Interface.Annu Rev Virol2018
29172071Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.Curr Opin Virol2017
28433705Maternal immunisation: collaborating with mother nature.Lancet Infect Dis2017
28477968Congenital cytomegalovirus infection undermines early development and functions of the human placenta.Placenta2017
27443522Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.Cell Host Microbe2016
27638253Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.Am J Pathol2016
25534746A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.Antimicrob Agents Chemother2015
25741001Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.J Virol2015
24403553Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.J Infect Dis2014
24651029HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.Viruses2014
24334684Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.Clin Vaccine Immunol2014
24492306Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets.MAbs2014
24257421Cytomegalovirus infection and antibody protection of the developing placenta.Clin Infect Dis2013
22959908Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model.Am J Pathol2012
21592978Have we overlooked congenital cytomegalovirus infection as a cause of stillbirth?J Infect Dis2011
20227052Screening for cytomegalovirus during pregnancy.Am J Obstet Gynecol2010
20651234Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.Am J Pathol2010
19854676Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.J Clin Virol2009
18349127Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.Am J Pathol2008
18637517Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge.Curr Top Microbiol Immunol2008
16822542Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis.Placenta2007
17314173Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta.J Virol2007
17317422Recent advances in the prevention and treatment of congenital cytomegalovirus infections.Semin Perinatol2007
17170095Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term.Endocrinology2007
16386950Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis.J Clin Virol2006
16565496Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.Am J Pathol2006
15817386Insights into viral transmission at the uterine-placental interface.Trends Microbiol2005
14990702Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro.J Virol2004
15272412Viral and bacterial pathogens at the maternal-fetal interface.J Infect Dis2004
14645586Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.J Virol2003
12490403Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts.Virology2002
10888620Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.J Virol2000
10482621An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.J Virol1999
9696834Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.J Virol1998
9621030A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin.J Virol1998
9188570The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.J Virol1997
9260696Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.J Med Virol1997
8558129Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells.J Gen Virol1996
8970961Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells.J Virol1996
8892927Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding.J Virol1996
7748487Conformation-defective herpes simplex virus 1 glycoprotein B activates the promoter of the grp94 gene that codes for the 94-kD stress protein in the endoplasmic reticulum.DNA Cell Biol1995
8668948Deletion mutants in human cytomegalovirus glycoprotein US9 are impaired in cell-cell transmission and in altering tight junctions of polarized human retinal pigment epithelial cells.Scand J Infect Dis Suppl1995
7778290Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.Virology1995
7952927Function of glycoprotein B homologues of the family herpesviridae.Infect Agents Dis1994
8184537Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.Virology1994
  • 1 - 50 of 118

Recommended Authors

Rockefeller University
Career Start Year 2011
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2001
Number of shared co-authors 1
Louisiana State University Health Sciences Center Shreveport
Career Start Year 2000
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 0
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
Career Start Year 1999
Number of shared co-authors 0
University of Arizona
Career Start Year 1996
Number of shared co-authors 1
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1991
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 0
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1988
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1981
Number of shared co-authors 0
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1978
Number of shared co-authors 1
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 1
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year 1973
Number of shared co-authors 0
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1960
Number of shared co-authors 0

Collaborators

Gladstone Institutes
Co-authored papers 22
Raigmore Hospital
Co-authored papers 9
Bayer HealthCare Pharmaceuticals
Co-authored papers 7
University of California San Francisco
Co-authored papers 6
University of California, USA Center for Reproductive Sciences san francisco
Co-authored papers 2
Indian Institute of Science Education and Research Pune
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Co-authored papers 1
The University of Sydney
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Stanford University
Co-authored papers 1
The University of British Columbia
Co-authored papers 1
Louisiana State University
Co-authored papers 1
Zhengzhou University
Co-authored papers 1
Universite Cote d'Azur, CNRS UMR5
Co-authored papers 1
Telethon Kids Institute
Co-authored papers 1
Co-authored papers 1
University of Minnesota-Twin Cities
Co-authored papers 1
Hadassah Hebrew University Medical Center
Co-authored papers 1